Crossmark

Remdesivir plus dexamethasone is associated to improve in the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status

Crossref DOI link: https://doi.org/10.1016/j.medcle.2023.03.027

Published Print: 2023-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Bernal, Enrique

García-Villalba, Eva

Pons, Eduardo

Hernández, Maria Dolores

Báguena, Carlos

Puche, Gabriel

Carter, Paula

Martinez, Mónica

Alcaraz, Antonia

Tomás, Cristina

Muñoz, Angeles

Vicente, Maria Rosario

Nuñez, Maria Luz

Sancho, Natalia

Villalba, Mari Carmen

Cano, Alfredo

Minguela, Alfredo
License Information

Text and Data Mining valid from 2023-08-01

stm-asf valid from 2023-08-01

stm-asf valid from 2023-08-01

stm-asf valid from 2023-08-01

stm-asf valid from 2023-08-01

stm-asf valid from 2023-08-01
More Information

This article is maintained by: Elsevier

Article Title: Remdesivir plus dexamethasone is associated to improve in the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2023.03.027

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below